Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma

Sivan Lieberman*, Eugene Libson, Bella Maly, Pinchas Lebensart, Dina Ben-Yehuda, Allan I. Bloom

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

OBJECTIVE. We estimated the accuracy and safety of imaging-guided needle biopsy for the diagnosis of suspected malignant lymphoma in patients with a splenic lesion. CONCLUSION. Imaging-guided small-bore cutting-edge needle biopsy of splenic lesions is a safe procedure. In most patients with primary or recurrent lymphoma, the disease subtype can be diagnosed reliably.

Original languageAmerican English
Pages (from-to)1025-1027
Number of pages3
JournalAmerican Journal of Roentgenology
Volume181
Issue number4
DOIs
StatePublished - 1 Oct 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma'. Together they form a unique fingerprint.

Cite this